Related Experiment Video

Updated: Jan 28, 2026

Real-Time Monitoring of Aurora kinase A Activation using Conformational FRET Biosensors in Live Cells
06:29

Real-Time Monitoring of Aurora kinase A Activation using Conformational FRET Biosensors in Live Cells

Published on: July 30, 2020

3.5K

Aurora B kinase as a novel molecular target for inhibition the growth of osteosarcoma

Zhenjiang Zhao1,2, Guoguo Jin1,2, Ke Yao1,2

  • 1The Hormel Institute, University of Minnesota, Austin, Minnesota.

Molecular Carcinogenesis
|February 22, 2019
PubMed

Insights

A novel compound, HOI-07, effectively inhibits Aurora B kinase, a key factor in osteosarcoma progression. This targeted therapy shows promise in suppressing tumor growth and inducing cancer cell death, offering a potential new treatment for bone cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Osteosarcoma is a primary bone cancer with poor long-term treatment outcomes.
  • Aurora B kinase is overexpressed in osteosarcoma and crucial for cell cycle regulation.
  • Current treatments for osteosarcoma have limited efficacy.

Purpose of the Study:

  • To investigate the efficacy of HOI-07, a specific Aurora B kinase inhibitor, against osteosarcoma.
  • To evaluate HOI-07's mechanism of action in osteosarcoma cells.
  • To assess HOI-07's therapeutic potential in preclinical models.

Main Methods:

  • In vitro studies on osteosarcoma cell lines to assess HOI-07's effects on cell viability, apoptosis, and cell cycle.
  • Gene knockdown experiments to confirm Aurora B kinase dependency.
  • In vivo xenograft mouse models to evaluate tumor suppression by HOI-07.

Main Results:

  • HOI-07 inhibited Aurora B kinase activity, induced apoptosis, and caused G2-M phase arrest in osteosarcoma cells.
  • Osteosarcoma sensitivity to HOI-07 was reduced by knocking down Aurora B expression.
  • HOI-07 suppressed xenograft tumor growth in mice without affecting body weight and reduced p-H3 (Ser10) levels.

Conclusions:

  • HOI-07 is a potent and specific Aurora B kinase inhibitor with significant anti-osteosarcoma activity.
  • HOI-07 demonstrates therapeutic potential for osteosarcoma treatment.
  • Further investigation of HOI-07 as an osteosarcoma therapeutic agent is warranted.
Keywords:
Aurora kinasesHOI-07mitosisosteosarcomatargeted therapy

More Related Videos

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models04:25

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Published on: October 28, 2021

11.4K
Characterization at the Molecular Level using Robust Biochemical Approaches of a New Kinase Protein11:23

Characterization at the Molecular Level using Robust Biochemical Approaches of a New Kinase Protein

Published on: June 30, 2019

6.7K

Related Concept Videos

Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
15.1K
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

4.5K
Molecular Weight of Step-Growth Polymers01:08

Molecular Weight of Step-Growth Polymers

Step growth polymerization involves bi or multifunctional monomers. Bifunctional monomers react to form linear step growth polymers, whereas multifunctional monomers react to form non-linear or branched polymers.
As the step-growth polymerization involves step-wise condensation of monomers, the molecular weight also builds up eventually. Consequently, high molecular weight polymers are obtained at the late stages of the polymerization, where 99% of monomers have been consumed.
The extent of the...
2.8K
Feedback Inhibition00:46

Feedback Inhibition

Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
57.1K
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
18.4K
Enzyme Inhibition01:30

Enzyme Inhibition

Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
92.1K